TargeGen's Other Investors

TargeGen raised a round of funding on , .

TargeGen, a vascular biology-focused biopharmaceutical company, discovers and develops small molecule kinase inhibitors that target vascular leakage, vascular proliferation, and inflammation.…

Articles about TargeGen's Other Investors: